Previous close | 3,048.00 |
Open | 3,106.00 |
Bid | 3,102.00 x 0 |
Ask | 3,106.00 x 0 |
Day's range | 3,056.00 - 3,110.00 |
52-week range | 2,728.00 - 3,861.00 |
Volume | |
Avg. volume | 261,255 |
Market cap | 3.114B |
Beta (5Y monthly) | 0.63 |
PE ratio (TTM) | 2,225.90 |
EPS (TTM) | 1.39 |
Earnings date | 30 Jul 2024 |
Forward dividend & yield | 0.79 (2.60%) |
Ex-dividend date | 16 May 2024 |
1y target est | 3,595.00 |
Acquisition of Micromeritics, which serves industries from oil processing to pharmaceuticals, also includes a deferred consideration of up to $53 million, the London-listed company said. Terry Kelly, CEO and president of Micromeritics, will be appointed president of Spectris' unit Malvern Panalytical. Spectris expects the deal to be accretive to earnings per share in the first year after the completion of the deal.
It's easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make...
Sumayya Mansoor breaks down why these two growth stocks look like no-brainer buys for her holdings to offer excellent growth and returns. The post 2 exciting growth stocks I’m looking to buy and hold for a decade! appeared first on The Motley Fool UK.